I love working with REACHnet as a patient partner because it is a reciprocal relationship. I have seen the results of my contributions shape research projects and patient engagement initiatives.
Do you want to be involved in finding effective treatments and cures for you or your loved ones’ health conditions? Become a REACHnet Patient Adviser. By sharing your story and health history, you can help researchers discover better treatments and cures.
REACHnet Patient Advisers:
Interested individuals can complete a simple online orientation as well as participate in an in-person meeting. If you want more information on the process, contact us at email@example.com.
REACHnet is a partnership among different Southern healthcare entities that connects patients, researchers, and healthcare providers for patient centered research. We want to make it easier for patients and their families to collaborate with healthcare professionals and researchers. To do this, REACHnet provides resources and technologies that support patient engagement and participation as participants on research projects as well as partners on research teams. Our research projects address obesity, diabetes, sickle cell disease, rare cancers, and more.
Launched in March 2014, REACHnet is a partnership between the Louisiana Public Health Institute, Ochsner Health System, Partnership for Achieving Total Health (PATH), Louisiana State University, Pennington Biomedical Research Center, Tulane University and Baylor Scott & White Health, and UMC.
Through REACHnet, we provide access to comprehensive clinical data for more than 3 million patients in Louisiana and Texas.
REACHnet is one of 13 Patient Centered Outcomes Institute (PCORI) funded Clinical Data Research Networks (CDRN). We work with local and national research partners to implement both small and large-scale pragmatic trials, which is a tool used by the health science community to test and evaluate the effectiveness of interventions in real-life routine practice conditions.
Because we work with a diverse patient population served by our partner health systems, we are able to support studies that recruit a highly representative sample of participants, which helps produce more informative evidence that has the potential to meaningfully inform healthcare decision-making.
REACHnet’s list of research projects is continually expanding, and includes areas of research such as weight management, Chronic Obstructive Pulmonary Disease (COPD), and Chronic Heart Failure (CHF).
With an additional $6.9M in funding from PCORI in 2015, REACHNet will continue to increase the capacity to conduct robust comparative effectiveness research. We engage researchers, healthcare partners, a variety of interested professionals, and patients and their families–just like you.
HIOH is another opportunity through REACHnet for patients and their families to take control of their health. We want to learn more about your treatment experience so we can help make things better.
To improve patient healthcare outcomes on the national and local level, we’ve designed and implemented the HIOH application suite for recruitment and engagement with patients just like you.
Health In Our Hands participants:
By collaborating with REACHnet as a Patient Adviser and through Health In Our Hands, you have the power to to ensure that the needs, perspectives, and lived experiences of patients and families are included throughout the research process–from asking the question, to finding the answer.
SMART IRB, the Streamlined, Multisite, Accelerated Resources for Trials IRB Reliance platform, is designed to harmonize and streamline the IRB review process for multisite studies, while ensuring a high level of protection for research participants.
Interested in using SMART IRB to facilitate single site review for your multisite study? Learn more about how you can use the SMART IRB Reliance Platform here.
Still have questions? Check out SMART IRB’s FAQ’s or contact us at the REACHnet Coordinating Center.
Because REACHnet is able to leverage technology to systematically manage data and recruit patients, we will be able to reduce the cost of doing research to the point whereby that savings can actually be allocated to doing additional science.